Notice/News
Notice/News
The external news articles in this bulletin have been collected and published solely for the purpose of providing information and may differ from our official position. We make no guarantee of the accuracy, timeliness, or completeness of the content of the article and are not liable for any direct or indirect damage that may occur.
Notice
[IR Pharm] [CTH-401] ② ToolGen-CARtherics CTH-401 Targets TAG-72 in 90% of Ovarian Cancers, Seeks Expansion into Solid Tumors
주식회사 툴젠
|2026.11.09
아이알팜에 당사 기사가 게재되었습니다.
자세한 내용은 아래 링크에서 확인하실 수 있습니다.
■ 기사 원문 : [CTH-401] ② 난소암 90% 표적 'TAG-72' 타격… 툴젠-카세릭스 'CTH-401', 고형암 확장 황금티켓 쥐나